Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Pautier

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
Pathologie-Biologie|December 1, 1992
[Advances in lung cancer]P Pautier
Presse Medicale (Paris, France : 1983)|April 12, 1997
[Surveillance of treated gynecological cancers]D Castaigne, P Pautier
La Revue Du Praticien|June 1, 1997
[First line chemotherapy of epithelial cancers of the ovary]C Lhommé, P Pautier
Annales De Cardiologie Et D'Angeiologie|October 1, 1995
[Chemotherapy and cardiotoxicity]C Brestescher, P Pautier, D Farge
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|February 18, 2004
[Cancer and pregnancy: the medical oncologist's point of view]P Pautier, C Lhommé, P Morice
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Tamoxifen-related uterine malignancies: carcinomas or sarcomas?S Delaloge, P Pautier, P Duvillard
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Replacement of carboplatin by oxaliplatin may be one solution for patients treated for ovarian carcinoma who are hypersensitive to carboplatinM Gutierrez, P Pautier, C Lhommé
Gynecologic Oncology|October 19, 2001
Prophylactic surgery in patients with inherited risk of ovarian cancerP Morice, P Pautier, S Delaloge
Gynecologie, Obstetrique, Fertilite & Senologie|February 1, 2020
[Borderline Ovarian Tumours: CNGOFS Guidelines for Clinical Practice - Hormonal Contraception and MHT/HRT after Borderline Ovarian Tumour]C Rousset-Jablonski, P Pautier, N Chopin
Critical Reviews in Oncology/Hematology|December 20, 2014
Novel membrane-based targets - Therapeutic potential in gynecological cancersM Gizzi, P Pautier, C Lhomme, et al.
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
Pathologie-Biologie|December 1, 1992
[Advances in lung cancer]P Pautier
Presse Medicale (Paris, France : 1983)|April 12, 1997
[Surveillance of treated gynecological cancers]D Castaigne, P Pautier
La Revue Du Praticien|June 1, 1997
[First line chemotherapy of epithelial cancers of the ovary]C Lhommé, P Pautier
Annales De Cardiologie Et D'Angeiologie|October 1, 1995
[Chemotherapy and cardiotoxicity]C Brestescher, P Pautier, D Farge
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction|February 18, 2004
[Cancer and pregnancy: the medical oncologist's point of view]P Pautier, C Lhommé, P Morice
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 17, 2004
Tamoxifen-related uterine malignancies: carcinomas or sarcomas?S Delaloge, P Pautier, P Duvillard
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Replacement of carboplatin by oxaliplatin may be one solution for patients treated for ovarian carcinoma who are hypersensitive to carboplatinM Gutierrez, P Pautier, C Lhommé
Gynecologic Oncology|October 19, 2001
Prophylactic surgery in patients with inherited risk of ovarian cancerP Morice, P Pautier, S Delaloge
Gynecologie, Obstetrique, Fertilite & Senologie|February 1, 2020
[Borderline Ovarian Tumours: CNGOFS Guidelines for Clinical Practice - Hormonal Contraception and MHT/HRT after Borderline Ovarian Tumour]C Rousset-Jablonski, P Pautier, N Chopin
Critical Reviews in Oncology/Hematology|December 20, 2014
Novel membrane-based targets - Therapeutic potential in gynecological cancersM Gizzi, P Pautier, C Lhomme, et al.
Pageof 15